BioCentury
ARTICLE | Politics, Policy & Law

Breaching the wall

Why importation legislation would be a blow to pharma’s reputation, not its wallet

March 11, 2017 12:37 AM UTC

President Trump has signaled his support for pharmaceutical importation, making it likely that legislation will be enacted to allow Americans to purchase drugs at the prices charged in Canada and possibly other countries.

One of the few things that could break its momentum would be overt opposition from Scott Gottlieb, the president’s choice to lead FDA, who has publicly stated that properly regulated importation wouldn’t save money. ...